(Q37210036)

19 August 2017

1 reference

title

Carbohydrate restriction as the default treatment for type 2 diabetes and metabolic syndrome (English)

1 reference

19 August 2017

0 references

1 reference

2

Jeff S Volek

1 reference

19 August 2017

Richard D Feinman

1

1 reference

19 August 2017

publication date

1 August 2008

1 reference

Scandinavian Cardiovascular Journal

19 August 2017

published in

1 reference

19 August 2017

volume

42

1 reference

19 August 2017

issue

4

1 reference

19 August 2017

page(s)

256-263

1 reference

Comparison of low fat and low carbohydrate diets on circulating fatty acid composition and markers of inflammation

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F14017430802014838

Carbohydrate restriction improves the features of Metabolic Syndrome. Metabolic Syndrome may be defined by the response to carbohydrate restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802014838

Effect of a high-protein, low-carbohydrate diet on blood glucose control in people with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802014838

Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802014838

Low-carbohydrate diet in type 2 diabetes. Stable improvement of bodyweight and glycemic control during 22 months follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802014838

Low carbohydrate diets in family practice: what can we learn from an internet-based support group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802014838

A low-carbohydrate, ketogenic diet to treat type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802014838

Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802014838

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1080%2F14017430802014838

The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802014838

FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802014838

Nonequilibrium thermodynamics and energy efficiency in weight loss diets

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802014838

The pathobiology of diabetic complications: a unifying mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14017430802014838

10.1080/14017430802014838

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference